PMA Application Toolkit
The six most critical PMA sections — nonclinical summary, clinical data summary, manufacturing information, benefit-risk analysis, and post-approval study protocol — built for FDA's review teams.
What You Get
PMA Application Structure Guide (21 CFR Part 814)
Complete framework for structuring a Premarket Approval application. Covers all required PMA modules: nonclinical studies, clinical investigations, manufacturing information, proposed labeling, bibliography, and summary of safety and effectiveness data (SSED). Includes FDA reviewer expectations for each section, common deficiency patterns, and the modular PMA strategy for complex devices.
Nonclinical Laboratory Studies Summary Template
Structured template for documenting bench testing, biocompatibility, sterilization validation, electrical safety, and animal studies in a PMA application. Covers FDA Good Laboratory Practice (GLP) citation requirements, study design rationale, acceptance criteria justification, and the summary format FDA review teams expect.
Clinical Data Summary Template (SSED Section)
Template for the clinical section of the PMA Summary of Safety and Effectiveness Data. Covers pivotal study design summary, patient population, primary and secondary endpoints, statistical analysis summary, adverse event tabulation, and the benefit-risk conclusion framing that FDA's review divisions respond to most favorably.
Manufacturing Information Checklist (21 CFR 814.20(b)(4))
Complete checklist for the manufacturing section of a PMA application. Covers facility information, manufacturing process description, process controls, QMS documentation references, device specifications, and the level of manufacturing detail FDA expects for Class III devices. Includes guidance on what to include vs. reference to the QSR/QMSR.
Benefit-Risk Summary Template
Structured benefit-risk analysis template aligned with FDA's benefit-risk framework for PMA decisions. Covers probable benefits, probable risks, patient tolerance for risk, availability of alternatives, and the overall benefit-risk conclusion. Pre-formatted for the SSED and designed to align with the factors FDA's approval panels formally weigh.
Post-Approval Study Protocol Template (21 CFR 814.82)
Complete protocol template for FDA-required post-approval studies. Covers study objectives, design rationale, enrollment criteria, endpoints, follow-up schedule, adverse event reporting, and the annual progress report format FDA requires for PAS compliance. Includes common PAS deficiency patterns that delay PMA approval.
Why It Works
Built for FDA's review process
Every section is structured the way FDA's review divisions read PMAs — not how regulatory textbooks describe them. The difference matters when a reviewer has 20 applications in queue.
Benefit-risk framing that works
The benefit-risk template is aligned with FDA's formal benefit-risk framework — the one advisory panels use for voting. Most sponsors write benefit-risk sections for lawyers, not for FDA reviewers.
Post-approval study ready
Most PMA approvals come with PAS conditions. The post-approval study protocol template is ready to attach to your PMA before approval so you are not scrambling after the letter arrives.
"PMA is the highest-stakes regulatory submission in medical devices. The difference between a complete and deficient PMA is often how the summary sections are structured — not the underlying data. These templates reflect what FDA's review divisions actually read."
"The benefit-risk summary template alone is worth multiples of the price. Getting that section right in a PMA determines whether FDA approves on the first advisory panel review or sends you back for another pivotal study."
FAQ
What is a PMA application?
A Premarket Approval (PMA) application is required for Class III medical devices that support or sustain life, prevent impairment, or present unreasonable risk. It is FDA's most rigorous device review pathway and requires valid scientific evidence demonstrating safety and effectiveness.
How is PMA different from 510(k)?
A 510(k) requires demonstrating substantial equivalence to a predicate device. A PMA requires independent valid scientific evidence — typically from a pivotal clinical study — demonstrating the device is safe and effective for its intended use. PMA is required for novel high-risk devices with no predicate.
What format are the documents?
All documents are editable Word and Excel templates structured for direct integration into an eCTD or paper PMA submission.
Ready to get started?
6 PMA templates. Instant access. Built for Class III device regulatory teams.
For informational purposes only. Not legal or regulatory advice. Legal